These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15999176)

  • 21. [Symptoms and treatment of depression in patients with diabetes].
    Suwalska A; Lojko D; Górna K; Rybakowski J
    Przegl Lek; 2004; 61(9):942-4. PubMed ID: 15803904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia.
    Schinner S; Kempf K; Overmann H; Willenberg HS; Schott M; Rose B; Scherbaum WA; Herder C
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S64-9. PubMed ID: 18777458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of acarbose in patients with beta-thalassaemia major and abnormal glucose homeostasis.
    Mangiagli A; Campisi S; De Sanctis V; Nicoletti MC; Cardinale G; Galati MC; Raiola G; Rigano P; Saviano A;
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():276-8. PubMed ID: 16462708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection.
    Mowla A; Karimi M; Afrasiabi A; De Sanctis V
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.
    Deedwania PC; Fonseca VA
    Am J Med; 2005 Sep; 118(9):939-47. PubMed ID: 16164876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the impact of a national pilot screening programme for type 2 diabetes in deprived areas of England.
    Goyder E; Wild S; Fischbacher C; Carlisle J; Peters J
    Fam Pract; 2008 Oct; 25(5):370-5. PubMed ID: 18765406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.
    Bajraktari G; Koltai MS; Ademaj F; Rexhepaj N; Qirko S; Ndrepepa G; Elezi S
    Int J Cardiol; 2006 Jun; 110(2):206-11. PubMed ID: 16297997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for and treating male depression.
    Geriatrics; 2004 Oct; 59(10):46. PubMed ID: 15508556
    [No Abstract]   [Full Text] [Related]  

  • 30. Clustering of coronary artery disease risk factors in patients with type 2 diabetes and impaired glucose tolerance.
    Sajjadi F; Mohammadifard N; Kelishadi R; Ghaderian N; Alikhasi H; Maghrun M
    East Mediterr Health J; 2008; 14(5):1080-9. PubMed ID: 19161080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of the impaired glucose metabolism and its association with risk factors for coronary artery disease in women with gestational diabetes.
    Rivero K; Portal VL; Vieira M; Behle I
    Diabetes Res Clin Pract; 2008 Mar; 79(3):433-7. PubMed ID: 18045723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of type 2 diabetes and other cardiovascular risk factors in a semirural area in Yemen.
    Gunaid AA; Assabri AM
    East Mediterr Health J; 2008; 14(1):42-56. PubMed ID: 18557451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.
    Madhu SV; Kant S; Srivastava S; Kant R; Sharma SB; Bhadoria DP
    Diabetes Res Clin Pract; 2008 Jun; 80(3):380-5. PubMed ID: 18321605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An audit of the first year of screening for depression in patients with diabetes and ischaemic heart disease under the Quality and Outcomes Framework.
    Subramanian DN; Hopayian K
    Qual Prim Care; 2008; 16(5):341-4. PubMed ID: 18973715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of arterial hemodynamics in patients with type 2 diabetes mellitus or impaired glucose tolerance.
    Milio G; Novo G; Ferrara F; Raimondi F; Novo S
    Int Angiol; 2006 Mar; 25(1):73-7. PubMed ID: 16520728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should oral glucose tolerance testing be mandatory following acute myocardial infarction?
    Jessani S; Gangopadhyay K; Patel JV; Lip GY; Millane T
    Int J Clin Pract; 2007 Apr; 61(4):680-3. PubMed ID: 17394440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
    Mavrogiannaki A; Karamanos B; Manesis EK; Papatheodoridis GV; Koskinas J; Archimandritis AJ
    J Viral Hepat; 2009 Jun; 16(6):430-6. PubMed ID: 19200136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes.
    Love-Osborne K; Butler N; Gao D; Zeitler P
    Pediatr Diabetes; 2006 Aug; 7(4):205-10. PubMed ID: 16911007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero.
    Tam WH; Ma RC; Yang X; Ko GT; Tong PC; Cockram CS; Sahota DS; Rogers MS; Chan JC
    Pediatrics; 2008 Dec; 122(6):1229-34. PubMed ID: 19047239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.